--- title: "Rajeev Saggar Sells 50,000 Shares of Liquidia (NASDAQ:LQDA) Stock" type: "News" locale: "en" url: "https://longbridge.com/en/news/296477852.md" description: "Liquidia insider Rajeev Saggar sold 50,000 shares on August 19 at an average price of $74.06, totaling approximately $3.7 million. This transaction reduced his holdings by 26.01%, leaving him with 142,265 shares valued at over $10.5 million. The sale was disclosed via SEC filing." datetime: "2026-08-20T10:53:06.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/296477852.md) - [en](https://longbridge.com/en/news/296477852.md) - [zh-HK](https://longbridge.com/zh-HK/news/296477852.md) generator: "portal-rs" --- # Rajeev Saggar Sells 50,000 Shares of Liquidia (NASDAQ:LQDA) Stock ## Key Points - **Liquidia insider Rajeev Saggar sold 50,000 shares** on August 19 at an average price of $74.06, generating approximately $3.70 million and reducing his holdings by 26.01% to 142,265 shares. - Liquidia reported quarterly revenue of **$171.68 million**, up 1,842.1% year over year and above estimates, but EPS of $0.74 narrowly missed the $0.76 consensus forecast. - Analyst sentiment is mixed: the stock has a consensus **“Hold” rating** and a $98.08 average price target, while shares recently opened at $75.33 and institutional investors owned 64.54% of the company. Liquidia Corporation (NASDAQ:LQDA - Get Free Report) insider Rajeev Saggar sold 50,000 shares of the company's stock in a transaction dated Wednesday, August 19th. The stock was sold at an average price of $74.06, for a total value of $3,703,000.00. Following the sale, the insider owned 142,265 shares of the company's stock, valued at $10,536,145.90. This represents a 26.01% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. - MarketBeat Week in Review: 12/25 - 12/29 Rajeev Saggar also recently made the following trade(s): - On Monday, August 17th, Rajeev Saggar sold 29,534 shares of Liquidia stock. The stock was sold at an average price of $76.84, for a total value of $2,269,392.56. - On Monday, July 13th, Rajeev Saggar sold 9,926 shares of Liquidia stock. The shares were sold at an average price of $71.51, for a total value of $709,808.26. ## Liquidia Price Performance LQDA opened at $75.33 on Thursday. The company has a 50 day moving average of $79.35 and a two-hundred day moving average of $55.93. The company has a quick ratio of 2.12, a current ratio of 2.31 and a debt-to-equity ratio of 0.63. Liquidia Corporation has a 52-week low of $21.15 and a 52-week high of $93.61. The company has a market cap of $6.74 billion, a P/E ratio of 54.99 and a beta of 0.58. * * * * * * - Liquidia: Court victory the awakening of an industry giant? Liquidia (NASDAQ:LQDA - Get Free Report) last issued its quarterly earnings data on Wednesday, August 12th. The company reported $0.74 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.76 by ($0.02). Liquidia had a net margin of 30.74% and a return on equity of 149.65%. The firm had revenue of $171.68 million during the quarter, compared to analyst estimates of $168.48 million. During the same period last year, the business earned ($0.49) EPS. The firm's revenue was up 1842.1% compared to the same quarter last year. On average, analysts expect that Liquidia Corporation will post 2.57 earnings per share for the current year. ## Analyst Ratings Changes Several analysts recently commented on the company. Raymond James Financial restated a "strong-buy" rating and issued a $106.00 target price on shares of Liquidia in a research report on Thursday, August 13th. Oppenheimer set a $75.00 price target on Liquidia in a report on Friday, June 5th. Royal Bank Of Canada set a $130.00 price target on shares of Liquidia in a research report on Friday, July 24th. Wells Fargo & Company raised their price objective on Liquidia from $62.00 to $108.00 and gave the stock an "overweight" rating in a research report on Thursday, August 13th. Finally, Lifesci Capital downgraded Liquidia from an "outperform" rating to a "hold" rating and set a $90.00 target price on the stock. in a research note on Wednesday, August 12th. One investment analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, three have assigned a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, Liquidia has a consensus rating of "Hold" and a consensus target price of $98.08. **Check Out Our Latest Research Report on LQDA** ## Institutional Investors Weigh In On Liquidia Institutional investors have recently added to or reduced their stakes in the stock. Farallon Capital Management LLC grew its position in Liquidia by 1.1% in the fourth quarter. Farallon Capital Management LLC now owns 8,656,038 shares of the company's stock valued at $298,547,000 after acquiring an additional 90,400 shares during the period. Vanguard Group Inc. raised its position in shares of Liquidia by 1.3% during the 4th quarter. Vanguard Group Inc. now owns 4,013,888 shares of the company's stock valued at $138,439,000 after acquiring an additional 52,671 shares during the last quarter. Opaleye Management Inc. raised its position in shares of Liquidia by 9.5% in the 2nd quarter. Opaleye Management Inc. now owns 2,475,000 shares of the company's stock valued at $30,838,000 after acquiring an additional 215,000 shares during the period. Bank of America Corp DE lifted its holdings in Liquidia by 18.7% during the first quarter. Bank of America Corp DE now owns 2,287,792 shares of the company's stock worth $86,341,000 after acquiring an additional 360,372 shares in the last quarter. Finally, Caprock Group LLC boosted its holdings in shares of Liquidia by 9.3% in the fourth quarter. Caprock Group LLC now owns 1,783,921 shares of the company's stock valued at $61,527,000 after buying an additional 151,832 shares during the period. 64.54% of the stock is owned by institutional investors and hedge funds. ## Liquidia Company Profile (Get Free Report) Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery. The company's lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH). ## See Also - Five stocks we like better than Liquidia - Bloom Energy’s AI Surge Meets a Valuation Reality Check - Target Is Winning Shoppers Back—Can the Rally Reach $180? - IonQ’s Space Contract Points to a New Frontier for Quantum Investors - Is Apple’s AI Strategy Smarter Than Skeptics Think? *This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to \[email protected\].* Insider Buying or Selling at Liquidia? Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Liquidia and related companies. From Our Partners The retirement stock I'd buy before Nvidia today In 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch... Chaikin Analytics This tiny launch company operates next to SpaceX and Blue Origin A small publicly traded company operates a specialized launch vehicle fleet inside the secure perimeter of Ken... Freedom Financial Someone just dumped the biggest gold fund. Investors pulled 2.9 billion dollars from the world's largest gold fund in a single day this March, pushing to... Behind the Markets Trump Takes Emergency Action - Plus Elon Musk's New Venture Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru... Altimetry They didn't warn anyone in 1971. This time someone is warning you. On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb... Reagan Gold Group Why major institutions are piling into this digital asset now BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t... Awesomely Man who Predicted Trump 2016 Win: “Prepare for Mid-Term Meltdown” In 2016, major election models gave Hillary Clinton a 99% chance of winning - but former CIA and Pentagon advi... Paradigm Press Central banks bought 710 tonnes - this fund pays monthly Gold is hitting new highs, fueled by tariffs and record central bank demand - 710 tonnes per quarter. JPMorgan... Investors Alley ### Related Stocks - [LQDA.US](https://longbridge.com/en/quote/LQDA.US.md) - [RJF.US](https://longbridge.com/en/quote/RJF.US.md) - [OPY.US](https://longbridge.com/en/quote/OPY.US.md) - [RY.US](https://longbridge.com/en/quote/RY.US.md) - [WFC.US](https://longbridge.com/en/quote/WFC.US.md) - [BAC.US](https://longbridge.com/en/quote/BAC.US.md) - [RJF-B.US](https://longbridge.com/en/quote/RJF-B.US.md) - [WFC-D.US](https://longbridge.com/en/quote/WFC-D.US.md) - [WFC-L.US](https://longbridge.com/en/quote/WFC-L.US.md) - [WFC-Y.US](https://longbridge.com/en/quote/WFC-Y.US.md) - [WFC-C.US](https://longbridge.com/en/quote/WFC-C.US.md) - [WFC-Z.US](https://longbridge.com/en/quote/WFC-Z.US.md) - [WFC-A.US](https://longbridge.com/en/quote/WFC-A.US.md) - [BAC-Q.US](https://longbridge.com/en/quote/BAC-Q.US.md) - [BML-L.US](https://longbridge.com/en/quote/BML-L.US.md) - [BAC-L.US](https://longbridge.com/en/quote/BAC-L.US.md) - [BAC-K.US](https://longbridge.com/en/quote/BAC-K.US.md) - [BML-H.US](https://longbridge.com/en/quote/BML-H.US.md) - [BAC-N.US](https://longbridge.com/en/quote/BAC-N.US.md) - [BAC-E.US](https://longbridge.com/en/quote/BAC-E.US.md) - [MER-K.US](https://longbridge.com/en/quote/MER-K.US.md) - [BAC-O.US](https://longbridge.com/en/quote/BAC-O.US.md) - [BML-G.US](https://longbridge.com/en/quote/BML-G.US.md) - [BAC-M.US](https://longbridge.com/en/quote/BAC-M.US.md) - [BAC-B.US](https://longbridge.com/en/quote/BAC-B.US.md) - [BML-J.US](https://longbridge.com/en/quote/BML-J.US.md) - [BAC-S.US](https://longbridge.com/en/quote/BAC-S.US.md) - [BAC-P.US](https://longbridge.com/en/quote/BAC-P.US.md) - [8648.JP](https://longbridge.com/en/quote/8648.JP.md) ## Related News & Research - [Liquidia (LQDA) Turns Profitable On YUTREPIA Growth, Is The Upside Already Priced In?](https://longbridge.com/en/news/296513877.md) - [Renaissance Technologies LLC Sells 198,753 Shares of Liquidia Corporation $LQDA](https://longbridge.com/en/news/296325354.md) - [Liquidia Chief Business Officer Jason Adair reports disposal of 73,631 common shares worth $5.09 million](https://longbridge.com/en/news/297022559.md) - [Liquidia director Katherine Rielly-Gauvin reports common share sale worth $4.08 million](https://longbridge.com/en/news/296650554.md) - [Mark Brosius Sells 77 Shares of Intuitive Surgical (NASDAQ:ISRG) Stock](https://longbridge.com/en/news/296661262.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**